|
**Overview**: ToRCH IgG Advantage Panel**Introduction**: The ToRCH IgG Advantage Panel is a diagnostic tool designed for congenital infection screening using serum samples. In India, Toxoplasma IgG avidity testing is crucial for dating primary infection in pregnancy (low avidity <3-4 months indicates recent exposure with high fetal risk), complementing IgG positivity. High morbidity from under-testing in rural/low-SES pregnant women with positive IgG/IgM, limited avidity labs, delayed risk stratification leading to unnecessary anxiety or missed defects. Per obstetrics practices aligned with ICMR, FOGSI, and National Health Mission guidelines, the test employs immunoassay for Toxoplasma IgG and IgG avidity over 1â€"2 days with high accuracy, valuable for confirming past vs recent infection. This diagnostic falls under infectious disease screening and targets pregnant women with positive Toxoplasma IgG/IgM or fetal anomalies, addressing accurate detection to guide reassurance (high avidity) or intervention (low avidity). With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise Toxoplasma timing and reducing congenital toxoplasmosis burden. Its serum-based approach ensures reliable IgG/avidity assessment.**Other Names**: Toxo IgG Adv Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/immunology/clinical pathology, compliant with 2025 standards.**Historical Milestone**: Toxoplasma IgG avidity standard for pregnancy risk; in India, integrated in high-risk antenatal.**Purpose**: The test assesses 2 parameters including Toxoplasma IgG to guide congenital infection screening, date exposure via avidity, inform counseling.**Test Parameters**: 1. Toxoplasma IgG, 2. Toxoplasma IgG Avidity.**Pretest Condition**: No fasting required; patients should be pregnant with positive IgG/IgM.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve antibody integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on gestational age, fever/rash.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of recent toxoplasmosis including fetal defects, benefits of avidity testing, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and calculate avidity within 1â€"2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Low avidity indicates recent infection (high fetal risk), necessitating specialist input.**Specialist Consultation**: Fetal medicine specialists or obstetricians should be consulted for management.**Additional Supporting Tests**: IgM, PCR on amniotic fluid for confirmation.**Test Limitations**: Avidity interpretation gestation-dependent; comprehensive approach required.**References**: Indian Journal of Obstetrics and Gynaecology 2024, TORCH Studies India 2023. |
